Skip to main content
Top
Published in: Obesity Surgery 4/2009

01-04-2009 | Research Article

Larrad Biliopancreatic Diversion in Sprague-Dawley Rats. Analysis of Weight Loss Related to Food Intake

Authors: Hugo Mendieta-Zerón, Álvaro Larrad-Jiménez, Gema Frühbeck, Katia Da Boit, C. Diéguez

Published in: Obesity Surgery | Issue 4/2009

Login to get access

Abstract

Background

Existing medical therapeutic strategies to achieve and maintain clinically significant weight loss in morbid obesity remain limited and the biliopancreatic diversion (BPD) is still the most effective among the bariatric surgical procedures. Our objective was to evaluate the weight and food intake after this procedure in a rat model.

Methods

Rats randomly underwent one of the following protocols (1) BPD (n = 12) versus sham (n = 12) with a follow-up period of 30 days and (2) BPD (n = 4) versus pair-fed (PF; n = 4) with a follow-up period of 50 days. Under intraperitoneal anesthesia with ketamine–xilacine, a subcardinal corpo-antral gastrectomy was made, preserving the gastric fundus that was anastomosed to a jejunal limb after dissecting the proximal jejunum 5 cm below the ligament of Treitz to form the alimentary limb. The biliopancreatic limb was terminolaterally anastomosed to the distal ileum 5 cm above the ileocecal valve to form the common limb. Sham animals underwent only abdominal incision. Weight and food intake were measured every day.

Results

In protocol 1, after postoperative day 30, BPD rats exhibited a mean weight reduction of 17.9% while shams increased 12.4%. There was no difference in food intake adjusted per 100 g of body weight. In protocol 2, after postoperative day 50, BPD rats had a mean weight reduction of 22.6% and, despite increasing their caloric intake from a mean of 42.6 after 6 days to 65.8 kcal/day after 50 days, they kept a similar mean weight of 344.0 and 340.2 g, respectively; on the contrary, PF rats exhibited a 30.8% body weight gain.

Conclusions

After the BPD, body weight is maintained independently of changes in food and energy intake.
Literature
1.
go back to reference WHO. Facts sheet on diabetes, obesity and overweight. 2006. WHO. Facts sheet on diabetes, obesity and overweight. 2006.
2.
go back to reference Nathan BM, Moran A. Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes 2008;15:21–9.CrossRefPubMed Nathan BM, Moran A. Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes 2008;15:21–9.CrossRefPubMed
3.
go back to reference Mark AL. Dietary therapy for obesity is a failure and pharmacotherapy is the future: a point of view. Clin Exp Pharmacol Physiol 2006;33:857–62.CrossRefPubMed Mark AL. Dietary therapy for obesity is a failure and pharmacotherapy is the future: a point of view. Clin Exp Pharmacol Physiol 2006;33:857–62.CrossRefPubMed
4.
go back to reference Ness-Abramof R, Apovian CM. Diet modification for treatment and prevention of obesity. Endocrine 2006;29:5–9.CrossRefPubMed Ness-Abramof R, Apovian CM. Diet modification for treatment and prevention of obesity. Endocrine 2006;29:5–9.CrossRefPubMed
5.
go back to reference Webb E, Viner R. Should metformin be prescribed to overweight adolescents in whom dietary/behavioural modifications have not helped? Arch Dis Child 2006;91:793–4.CrossRefPubMedPubMedCentral Webb E, Viner R. Should metformin be prescribed to overweight adolescents in whom dietary/behavioural modifications have not helped? Arch Dis Child 2006;91:793–4.CrossRefPubMedPubMedCentral
6.
go back to reference O’Brien PE, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg 2006;16:1032–40.CrossRefPubMed O’Brien PE, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg 2006;16:1032–40.CrossRefPubMed
7.
go back to reference Shen R, Dugay G, Rajaram K, et al. Impact of patient follow-up on weight loss after bariatric surgery. Obes Surg 2004;14:514–9.CrossRefPubMed Shen R, Dugay G, Rajaram K, et al. Impact of patient follow-up on weight loss after bariatric surgery. Obes Surg 2004;14:514–9.CrossRefPubMed
8.
go back to reference Angstadt J, Whipple O. Developing a new bariatric surgery program. Am Surg 2007;73:1092–7.PubMed Angstadt J, Whipple O. Developing a new bariatric surgery program. Am Surg 2007;73:1092–7.PubMed
9.
go back to reference Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005;142:547–59.CrossRefPubMed Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005;142:547–59.CrossRefPubMed
10.
go back to reference Collins BJ, Miyashita T, Schweitzer M, et al. Gastric bypass: why Roux-en-Y? A review of experimental data. Arch Surg 2007;142:1000–3.CrossRefPubMed Collins BJ, Miyashita T, Schweitzer M, et al. Gastric bypass: why Roux-en-Y? A review of experimental data. Arch Surg 2007;142:1000–3.CrossRefPubMed
11.
go back to reference Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004;89:2608–15.CrossRefPubMed Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004;89:2608–15.CrossRefPubMed
13.
go back to reference Cummings DE, Overduin J, Shannon MH, et al. Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery. Surg Obes Relat Dis 2005;1:358–68.CrossRefPubMed Cummings DE, Overduin J, Shannon MH, et al. Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery. Surg Obes Relat Dis 2005;1:358–68.CrossRefPubMed
14.
go back to reference Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: 1. An experimental study in dogs. Br J Surg 1979;66:613–7.CrossRefPubMed Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: 1. An experimental study in dogs. Br J Surg 1979;66:613–7.CrossRefPubMed
15.
go back to reference Larrad-Jiménez A, Álvarez MP, Fernández MP, et al. Larrad biliopancreatic diversion. Description of an rat experimental model. Cir Esp 2008;83:89–92.CrossRefPubMed Larrad-Jiménez A, Álvarez MP, Fernández MP, et al. Larrad biliopancreatic diversion. Description of an rat experimental model. Cir Esp 2008;83:89–92.CrossRefPubMed
16.
go back to reference Marinari GM, Murelli F, Camerini G, et al. A 15-year evaluation of biliopancreatic diversion according to the Bariatric Analysis Reporting Outcome System (BAROS). Obes Surg 2004;14:325–8.CrossRefPubMed Marinari GM, Murelli F, Camerini G, et al. A 15-year evaluation of biliopancreatic diversion according to the Bariatric Analysis Reporting Outcome System (BAROS). Obes Surg 2004;14:325–8.CrossRefPubMed
17.
go back to reference Larrad-Jiménez A, Díaz-Guerra CS, de Cuadros BP, et al. Short-, mid- and long-term results of Larrad biliopancreatic diversion. Obes Surg 2007;17:202–10.CrossRefPubMed Larrad-Jiménez A, Díaz-Guerra CS, de Cuadros BP, et al. Short-, mid- and long-term results of Larrad biliopancreatic diversion. Obes Surg 2007;17:202–10.CrossRefPubMed
18.
go back to reference Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg 2005;15:408–16.CrossRefPubMed Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg 2005;15:408–16.CrossRefPubMed
19.
go back to reference Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004;240:416–23.CrossRefPubMedPubMedCentral Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004;240:416–23.CrossRefPubMedPubMedCentral
20.
go back to reference le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006;243:108–14.CrossRefPubMedPubMedCentral le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006;243:108–14.CrossRefPubMedPubMedCentral
21.
go back to reference Young EA, Taylor MM, Taylor MK, et al. Gastric stapling for morbid obesity: gastrointestinal response in a rat model. Am J Clin Nutr 1984;40:293–302.CrossRefPubMed Young EA, Taylor MM, Taylor MK, et al. Gastric stapling for morbid obesity: gastrointestinal response in a rat model. Am J Clin Nutr 1984;40:293–302.CrossRefPubMed
23.
go back to reference Geliebter A, Westreich S, Gage D, et al. Intragastric balloon reduces food intake and body weight in rats. Am J Physiol 1986;251:R794–7.PubMed Geliebter A, Westreich S, Gage D, et al. Intragastric balloon reduces food intake and body weight in rats. Am J Physiol 1986;251:R794–7.PubMed
24.
go back to reference Xu Y, Ohinata K, Meguid MM, et al. Gastric bypass model in the obese rat to study metabolic mechanisms of weight loss. J Surg Res 2002;107:56–63.CrossRefPubMed Xu Y, Ohinata K, Meguid MM, et al. Gastric bypass model in the obese rat to study metabolic mechanisms of weight loss. J Surg Res 2002;107:56–63.CrossRefPubMed
25.
go back to reference Furnes MW, Stenstrom B, Tommeras K, et al. Feeding behavior in rats subjected to gastrectomy or gastric bypass surgery. Eur Surg Res 2008;40:279–88.CrossRefPubMed Furnes MW, Stenstrom B, Tommeras K, et al. Feeding behavior in rats subjected to gastrectomy or gastric bypass surgery. Eur Surg Res 2008;40:279–88.CrossRefPubMed
26.
go back to reference Borg CM, le Roux CW, Ghatei MA, et al. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg 2007;17:1193–8.CrossRefPubMed Borg CM, le Roux CW, Ghatei MA, et al. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg 2007;17:1193–8.CrossRefPubMed
27.
go back to reference Guijarro A, Suzuki S, Chen C, et al. Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol 2007;293:R1474–89.CrossRefPubMed Guijarro A, Suzuki S, Chen C, et al. Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol 2007;293:R1474–89.CrossRefPubMed
28.
go back to reference Sánchez-Cabezudo Díaz-Guerra C, Larrad-Jiménez A. Analysis of weight loss with the biliopancreatic diversion of Larrad: absolute failures or relative successes? Obes Surg 2002;12:249–52.CrossRefPubMed Sánchez-Cabezudo Díaz-Guerra C, Larrad-Jiménez A. Analysis of weight loss with the biliopancreatic diversion of Larrad: absolute failures or relative successes? Obes Surg 2002;12:249–52.CrossRefPubMed
29.
go back to reference Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683–93.CrossRefPubMed Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683–93.CrossRefPubMed
30.
go back to reference Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg 2005;15:692–9.CrossRefPubMed Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg 2005;15:692–9.CrossRefPubMed
31.
go back to reference Ballantyne GH. Peptide YY(1–36) and peptide YY(3–36): part II. Changes after gastrointestinal surgery and bariatric surgery. Obes Surg 2006;16:795–803.CrossRefPubMed Ballantyne GH. Peptide YY(1–36) and peptide YY(3–36): part II. Changes after gastrointestinal surgery and bariatric surgery. Obes Surg 2006;16:795–803.CrossRefPubMed
32.
go back to reference Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741–9.CrossRefPubMedPubMedCentral Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741–9.CrossRefPubMedPubMedCentral
Metadata
Title
Larrad Biliopancreatic Diversion in Sprague-Dawley Rats. Analysis of Weight Loss Related to Food Intake
Authors
Hugo Mendieta-Zerón
Álvaro Larrad-Jiménez
Gema Frühbeck
Katia Da Boit
C. Diéguez
Publication date
01-04-2009
Publisher
Springer New York
Published in
Obesity Surgery / Issue 4/2009
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9710-9

Other articles of this Issue 4/2009

Obesity Surgery 4/2009 Go to the issue